◆英語タイトル：ZIOPHARM Oncology Inc (ZIOP) - Financial and Strategic SWOT Analysis Review
Ziopharm Oncology Inc (Ziopharm), is a provider of next-generation immune therapies. The company offers Controlled IL-12 and t-cell therapy to fight blood cancers and solid tumors. Its Controlled IL-12 platform provides therapy for cold tumors by turning them hot by activating an immune response. The company also provides Sleeping Beauty, a clinically-advanced non-viral cell therapy technology which helps in the manufacturing of genetically modified chimeric antigen receptors (CARs) and T-cell receptors (TCRs) targeting specific tumor-derived antigens. Its products and technologies are used in the treatment of hematologic malignancies, solid tumors and graft-versus-host-disease. Ziopharm is headquartered in Boston, Massachusetts, the US.
ZIOPHARM Oncology Inc Key Recent Developments
Mar 05,2019: Ziopharm Oncology reports fourth quarter and full year 2018 financial results and provides corporate update
Feb 21,2019: Ziopharm Oncology CEO to present at the CAR-TCR Summit Europe
Dec 13,2018: Ziopharm Oncology promotes Dr. David Mauney to president
Oct 16,2018: Ziopharm Oncology announces changes to board of directors and management team
Sep 04,2018: Ziopharm Oncology announces Scott Braunstein, M.D., operating partner at Aisling Capital, nominated to Board of Directors
This comprehensive SWOT profile of ZIOPHARM Oncology Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of ZIOPHARM Oncology Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).
The profile contains critical company information including*,
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note*: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include,
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Table of Contents
Section 1 – About the Company
ZIOPHARM Oncology Inc – Key Information
ZIOPHARM Oncology Inc – Overview
ZIOPHARM Oncology Inc – Key Employees
ZIOPHARM Oncology Inc – Key Employee Biographies
ZIOPHARM Oncology Inc – Key Operational Heads
ZIOPHARM Oncology Inc – Major Products and Services
ZIOPHARM Oncology Inc – History
ZIOPHARM Oncology Inc – Company Statement
ZIOPHARM Oncology Inc – Locations And Subsidiaries
ZIOPHARM Oncology Inc – Key Manufacturing facilities
Other Locations & Subsidiaries
Section 2 – Company Analysis
ZIOPHARM Oncology Inc – Business Description
ZIOPHARM Oncology Inc – Corporate Strategy
ZIOPHARM Oncology Inc – SWOT Analysis
SWOT Analysis – Overview
ZIOPHARM Oncology Inc – Strengths
ZIOPHARM Oncology Inc – Weaknesses
ZIOPHARM Oncology Inc – Opportunities
ZIOPHARM Oncology Inc – Threats
ZIOPHARM Oncology Inc – Key Competitors
Section 3 – Company Financial Performance Charts
ZIOPHARM Oncology Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Appendix
Note*: Some sections may be missing if data is unavailable for the company
List of Tables
ZIOPHARM Oncology Inc, Key Information
ZIOPHARM Oncology Inc, Key Ratios
ZIOPHARM Oncology Inc, Share Data
ZIOPHARM Oncology Inc, Major Products and Services
ZIOPHARM Oncology Inc, History
ZIOPHARM Oncology Inc, Key Employees
ZIOPHARM Oncology Inc, Key Employee Biographies
ZIOPHARM Oncology Inc, Key Operational Heads
ZIOPHARM Oncology Inc, Other Locations
ZIOPHARM Oncology Inc, Subsidiaries
ZIOPHARM Oncology Inc, Key Manufacturing facilities
ZIOPHARM Oncology Inc, Key Competitors
ZIOPHARM Oncology Inc, SWOT Analysis
ZIOPHARM Oncology Inc, Ratios based on current share price
ZIOPHARM Oncology Inc, Annual Ratios
ZIOPHARM Oncology Inc, Interim Ratios
Capital Market Ratios
List of Figures
ZIOPHARM Oncology Inc, Performance Chart
ZIOPHARM Oncology Inc, Ratio Charts
| ★海外企業調査レポート[ZIOPHARM Oncology Inc (ZIOP)：企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら